![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, November 27, 2023 11:16:25 PM
I mention this because the surreptitious control of an entity, through the exercise of warrants, was part of the news announced with the previous recall of our loaned shares. In addition, this company is where Ed Jordan is now the chief commercial officer. It's feasible that we will see that Humanigen has taken an ownership stake in the company, even if it doesn't amount to control.
https://xspraypharma.com/modular_finance_pressmeddelande/xspray-pharma-appoints-chief-commercial-officer-to-drive-upcoming-dasynoc-us-product-commercialization/
Lenz could prove to have a pivotal role in eliminating the black box warning for Xspray's nilotinib (TASIGNA) in the US.
https://xspraypharma.com/modular_finance_pressmeddelande/xspray-pharmas-xs003-achieves-superior-bioavailability-milestone-matching-tasigna-at-reduced-dosage/
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM